Sacramento California Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• County: Sacramento
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages A Sacramento California Collateral License Agreement is a legal agreement between Gentling, Inc., a company specializing in genetics and biotechnology, and The University of North Texas Health Science Center. This agreement establishes the terms and conditions under which Gentling will have access to certain licensed intellectual property owned by the University for commercial purposes, specifically in the context of collateral usage. Keywords: Sacramento California, Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, intellectual property, commercial purposes, collateral usage. There are several types of Collateral License Agreements that can exist between Gentling, Inc. and The University of North Texas Health Science Center, depending on the scope and purpose of the licensed intellectual property. These may include: 1. Research Collaborative Collateral License Agreement: This type of agreement allows Gentling to use licensed intellectual property from the University specifically for collaborative research projects. The agreement will outline the terms and conditions regarding confidentiality, ownership, and the rights of each party involved. 2. Technology Transfer Collateral License Agreement: When the University has developed a specific technology or invention, this type of agreement allows Gentling to gain the rights to use, develop, and commercialize the technology. It includes provisions for royalties, sublicensing, patent filings, and other relevant aspects. 3. Product Development Collateral License Agreement: In cases where Gentling intends to use the University's licensed intellectual property to develop specific products, this agreement outlines the terms and conditions relevant to product development, marketing, sales, and distribution. 4. Exclusive Collateral License Agreement: If Gentling seeks exclusive rights to the University's intellectual property within a certain field or market, this agreement grants them sole access and prohibits the University from granting similar licenses to other parties. This type of agreement often involves higher financial considerations and extended-term lengths. 5. Non-Exclusive Collateral License Agreement: Unlike an exclusive agreement, a non-exclusive Collateral License Agreement allows Gentling to use the University's licensed intellectual property alongside other parties. This enables multiple commercial collaborations without restricting the University in licensing its intellectual property to other interested entities. Regardless of the type, a Sacramento California Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center aims to foster a mutually beneficial relationship by establishing clear guidelines, rights, and obligations regarding the usage of licensed intellectual property in commercial activities.

A Sacramento California Collateral License Agreement is a legal agreement between Gentling, Inc., a company specializing in genetics and biotechnology, and The University of North Texas Health Science Center. This agreement establishes the terms and conditions under which Gentling will have access to certain licensed intellectual property owned by the University for commercial purposes, specifically in the context of collateral usage. Keywords: Sacramento California, Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, intellectual property, commercial purposes, collateral usage. There are several types of Collateral License Agreements that can exist between Gentling, Inc. and The University of North Texas Health Science Center, depending on the scope and purpose of the licensed intellectual property. These may include: 1. Research Collaborative Collateral License Agreement: This type of agreement allows Gentling to use licensed intellectual property from the University specifically for collaborative research projects. The agreement will outline the terms and conditions regarding confidentiality, ownership, and the rights of each party involved. 2. Technology Transfer Collateral License Agreement: When the University has developed a specific technology or invention, this type of agreement allows Gentling to gain the rights to use, develop, and commercialize the technology. It includes provisions for royalties, sublicensing, patent filings, and other relevant aspects. 3. Product Development Collateral License Agreement: In cases where Gentling intends to use the University's licensed intellectual property to develop specific products, this agreement outlines the terms and conditions relevant to product development, marketing, sales, and distribution. 4. Exclusive Collateral License Agreement: If Gentling seeks exclusive rights to the University's intellectual property within a certain field or market, this agreement grants them sole access and prohibits the University from granting similar licenses to other parties. This type of agreement often involves higher financial considerations and extended-term lengths. 5. Non-Exclusive Collateral License Agreement: Unlike an exclusive agreement, a non-exclusive Collateral License Agreement allows Gentling to use the University's licensed intellectual property alongside other parties. This enables multiple commercial collaborations without restricting the University in licensing its intellectual property to other interested entities. Regardless of the type, a Sacramento California Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center aims to foster a mutually beneficial relationship by establishing clear guidelines, rights, and obligations regarding the usage of licensed intellectual property in commercial activities.